A consecutive case series experience with [(18) F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition

BACKGROUND: Identification and quantification of fibrillar amyloid in brain using positron emission tomography (PET) imaging and Amyvid™ ([(18) F] Amyvid, [(18) F] florbetapir, (18) F-AV-45) was recently approved by the US Food and Drug Administration as a clinical tool to estimate brain amyloid bur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsis, Effie M, Bender, Heidi A, Kostakoglu, Lale, Machac, Josef, Martin, Jane, Woehr, Jennifer L, Sewell, Margaret C, Aloysi, Amy, Goldstein, Martin A, Li, Clara, Sano, Mary, Gandy, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913628/
https://www.ncbi.nlm.nih.gov/pubmed/24484858
http://dx.doi.org/10.1186/1750-1326-9-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913628/
https://www.ncbi.nlm.nih.gov/pubmed/24484858
http://dx.doi.org/10.1186/1750-1326-9-10

Ejemplares similares